Treatment of Patients With Advanced Rectum Cancer With Capecitabine and Oxaliplatin Before, Under and After Radiation and With Adding Cetuximab to K-RAS Wild-type Patients

Phase 2UnknownNCT00964457

Copenhagen University Hospital at Herlev60 enrolled

Overview

response rate to adding cetuximab, oxaliplatin and capecitabine to radiation for advanced rectum cancer

Dynamic MRI will be used to monitor the effect of the treatment and will be compared to pathologic results.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

cetuximab 500mg per meter square every second week

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * advanced rectum cancer Exclusion Criteria: * prior radiation

Herlev Hospital

Herlev, Denmark

response rate

Time frame: 3 years

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.